Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth

The 2014 document examines the intricate connections between polycystic ovary syndrome (PCOS), insulin resistance (IR), and obesity, emphasizing the reciprocal relationship between IR and hyperandrogenemia, with obesity exacerbating the condition. It discusses the impact of PCOS on sebaceous gland sensitivity, leading to acne and seborrhea, and notes that 67% of women with alopecia areata also have PCOS. The review explains how IR and hyperinsulinemia contribute to increased androgen secretion, creating a cycle that worsens IR and hyperandrogenemia, and subsequently leads to comorbidities like type 2 diabetes and cardiovascular disease. It also describes the selective insulin resistance in ovarian physiology, the role of dietary patterns in PCOS, and the distinct features of PCOS in nonobese women. The document concludes that while genetic factors play a role, IR and obesity are central to the etiopathogenesis and progression of PCOS, and that lifestyle modifications should be prioritized in management strategies. Further research is called for to improve understanding and treatment of PCOS, particularly concerning fertility outcomes.